110 related articles for article (PubMed ID: 8238182)
1. Are pill counts valid measures of compliance in clinical obstetric trials?
DuBard MB; Goldenberg RL; Copper RL; Hauth JC
Am J Obstet Gynecol; 1993 Nov; 169(5):1181-2. PubMed ID: 8238182
[TBL] [Abstract][Full Text] [Related]
2. Umbilical cord serum levels of thromboxane B2 in term infants of women who participated in a placebo-controlled trial of low-dose aspirin.
Parker CR; Hauth JC; Goldenberg RL; Cooper RL; Dubard MB
J Matern Fetal Med; 2000; 9(4):209-15. PubMed ID: 11048830
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum thromboxane B2 reduction versus pregnancy outcome in a low-dose aspirin trial.
Hauth JC; Goldenberg RL; Parker CR; Copper RL; Cutter GR
Am J Obstet Gynecol; 1995 Aug; 173(2):578-84. PubMed ID: 7645637
[TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin therapy to prevent preeclampsia.
Hauth JC; Goldenberg RL; Parker CR; Philips JB; Copper RL; DuBard MB; Cutter GR
Am J Obstet Gynecol; 1993 Apr; 168(4):1083-91; discussion 1091-3. PubMed ID: 8475955
[TBL] [Abstract][Full Text] [Related]
5. [Low-dose aspirin preventing pregnancy induced hypertension].
Cheng WW; Zhang ZJ
Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):342-5, 387. PubMed ID: 1804603
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
[TBL] [Abstract][Full Text] [Related]
7. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Sibai BM; Caritis SN; Thom E; Klebanoff M; McNellis D; Rocco L; Paul RH; Romero R; Witter F; Rosen M
N Engl J Med; 1993 Oct; 329(17):1213-8. PubMed ID: 8413387
[TBL] [Abstract][Full Text] [Related]
8. The effect of low-dose aspirin on umbilical artery Doppler measurements.
Owen J; Maher JE; Hauth JC; Goldenberg RL; Parker CR
Am J Obstet Gynecol; 1993 Oct; 169(4):907-11. PubMed ID: 8238148
[TBL] [Abstract][Full Text] [Related]
9. Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
Heyborne KD
Am J Obstet Gynecol; 2000 Sep; 183(3):523-8. PubMed ID: 10992168
[TBL] [Abstract][Full Text] [Related]
10. How important is aspirin adherence when evaluating effectiveness of low-dose aspirin?
Navaratnam K; Alfirevic Z; Pirmohamed M; Alfirevic A
Eur J Obstet Gynecol Reprod Biol; 2017 Dec; 219():1-9. PubMed ID: 29024912
[TBL] [Abstract][Full Text] [Related]
11. [Prevention of preeclampsia].
Desvaux D; Haddad B
Presse Med; 2003 Oct; 32(33):1559-65. PubMed ID: 14576595
[TBL] [Abstract][Full Text] [Related]
12. A meta-analysis of low-dose aspirin for prevention of preeclampsia.
Trivedi NA
J Postgrad Med; 2011; 57(2):91-5. PubMed ID: 21654128
[TBL] [Abstract][Full Text] [Related]
13. [Low-dose aspirin in prevention and therapy of hypertension in pregnancy].
Schröcksnadel H; Sitte B; Alge A; Steckel-Berger G; Daxenbichler G; Dapunt O
Gynakol Geburtshilfliche Rundsch; 1992; 32 Suppl 1():90-1. PubMed ID: 1286358
[No Abstract] [Full Text] [Related]
14. Low-dose aspirin prevents pregnancy-induced hypertension and pre-eclampsia in angiotensin-sensitive primigravidae.
Wallenburg HC; Dekker GA; Makovitz JW; Rotmans P
Lancet; 1986 Jan; 1(8471):1-3. PubMed ID: 2867260
[TBL] [Abstract][Full Text] [Related]
15. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials.
Villa PM; Kajantie E; Räikkönen K; Pesonen AK; Hämäläinen E; Vainio M; Taipale P; Laivuori H;
BJOG; 2013 Jan; 120(1):64-74. PubMed ID: 23126307
[TBL] [Abstract][Full Text] [Related]
16. The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis.
Roberge S; Nicolaides K; Demers S; Hyett J; Chaillet N; Bujold E
Am J Obstet Gynecol; 2017 Feb; 216(2):110-120.e6. PubMed ID: 27640943
[TBL] [Abstract][Full Text] [Related]
17. Biochemical markers of compliance in the Physicians' Health Study.
Satterfield S; Greco PJ; Goldhaber SZ; Stampfer MJ; Swartz SL; Stein EA; Kaplan L; Hennekens CH
Am J Prev Med; 1990; 6(5):290-4. PubMed ID: 2268456
[TBL] [Abstract][Full Text] [Related]
18. Early prediction and aspirin for prevention of pre-eclampsia (EPAPP) study: a randomized controlled trial.
Odibo AO; Goetzinger KR; Odibo L; Tuuli MG
Ultrasound Obstet Gynecol; 2015 Oct; 46(4):414-8. PubMed ID: 25914193
[TBL] [Abstract][Full Text] [Related]
19. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Caritis S; Sibai B; Hauth J; Lindheimer MD; Klebanoff M; Thom E; VanDorsten P; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G
N Engl J Med; 1998 Mar; 338(11):701-5. PubMed ID: 9494145
[TBL] [Abstract][Full Text] [Related]
20. Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention.
Moore GS; Allshouse AA; Winn VD; Galan HL; Heyborne KD
Pregnancy Hypertens; 2015 Oct; 5(4):280-6. PubMed ID: 26597741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
